Themmen APN, Brunner JUI. Luteinizing hormone receptor mutations and sex differentiation. Hur J Kndocrinol DWh;l i4 :S H 40. ISSN 0S04~-4h4 5 M mat ions in the luteinizing hormone (LI I) receptor gene have been found in patients with a h norm a lilies in I heir sexual differentiation. In this paper we review results obtained in the studies ol these LI I receptor mutations. Activating and inactivating mutations are discussed with respect to the mechanism ol action of LI I/hunum chorionic gonadotrophin but also in light of their impact of the present knowledge ol the physiology of sex differentiation and gonadal function. * I activate the phosphatidylinositide pathway, indicating involvement of ti,, (15, IS). Hither LH-or hCO stiinulated adenylyl cyclase results in an increase of the cellular cAMP level, activation of cAMP-dependent protein kinase and phosphorylation of several proteins. Recently, an interesting substrate for phosphorylation was detected in steroidogenic cell types. The protein, steroidogenic acute regulatory protein (StAR), is a mitochondrial protein with a short half-life (.19) that is involved in the transport of cholesterol through the inner mitochondrial membrane. Mutations in STAR
In Ihe process of sex differentiation two major switches can be distinguished. First, expression of the SKY (sexdetermining region Y) gene on the Y chromosome is responsible for induction of testis formation from the indifferent gonads (1, 2) , a process that also requires other autosomal or X chromosomal genes. Subse quently, the differentiating testicular cells establish hormonal control of further development of Ihe urogenital trad and sinus. The Sertoli cells of the fetal testis secrete untLMiillcrian hormone (AMH), a member of the transforming growth lador-./ (TCil-Vi/aetivin family of growth anti differentiation factors til. Anti-Miillerian hormone binds to an AMH receptor that is present in the mesenchymal cells surrounding the female anlagen of the urogenital trad, the Mullerian ducts (4. S). The action of AMH results in regression in (he Mullerian ducts in the male. Development of male internal and external genitalia is dependent on the Leydig cell protlncl testosterone, which in some large! tissues is converted to dihvdrotestosterone (b). The Wolffian duds, the anlagen of the male urogenital tract, develop into the epididymides, vasa deferentia and seminal vesicles. The other male internal and external genitalia are also formed under the iniluenee of androgens: the prostate, penis and scrotum.
The obligatory role of androgens in sex differentiation is exemplilied bv the female external phenotype of 4h.\Y individuals that are insensitive to androgens because of mutations in their androgens receptor gene (7).
Androgens are produced bv a single cell type in the testis, the I.eydig cells (for reviews see Refs. S and into the gonads during the period of formation of the bipotential gonads (10). Human fetal Leydig cells initially differentiate and proliferate under the influence of htYi (11), Subsequently, after the establishment of the pituitary-gonadal axis, LII comes into play. Fetal Leydig cell activity is responsible for virilization of the male internal and external genitalia. Postnatally and in childhood, LII levels are low. During puberty rising LH levels again stimulate Leydig cell to start producing androgens, which results in the establishment, of the adult male secondary sexual characteristics.
Both litXl and LH signal through the LH receptor. The LII receptor belongs to the class of GTP binding protein (Cl protein' l-coupled receptor that display specific fea tures such as a domain of seven transmembrane helices (12. 1 i). The LH rece for TSII and I\SH are characterized by an additional large extracellular domain that contains 14 leucinerich repeats and is responsible for ligand binding (1 4 -17) . The subgroup of C l protein-coupled receptors transduces the signal of the hormone mainly to adenylyl cyclase through the stimulatory G protein t;v In addition, TSH and LH have been shown to 5 34 AVN Themmen und HG Brunner i; i H | I'NIK K'KINOI, 14'M, . | M that inactivate the protein also cause congenital lipoid adrenal hyperplasia (20), which indicates the impor tance of STAR in steroidogenesis. The STAR-activated transport of cholesterol results in increased availability of the lipid to the Leydig cell mitochondrial cytochrome P-450 cholesterol side-chain cleavage enzyme that converts cholesterol into pregnenolone. Pregnenolone subsequently diffuses out of the mitochondria to the smooth endoplasmic reticulum where it is converted to testosterone.
Luteinizing hormone receptor expression studies have been mainly performed in the rat and mouse. Leydig cell expression of LH receptor mRNA can be found as early as at 15 days post coitum in the rat (21) . However, the alternatively spliced mRNA species expressed in these early Leydig cells do not encode the complete receptor protein molecule, and produce truncated LH receptors that are inactive because they cannot couple to Gs. Messenger RNA molecules that encode a functional full-length LH receptor are expressed approximately 1 day later (21); in the ovary this transition takes more than 2 weeks (22), The physiological significance of these alternative splicing products is unclear, although it has been suggested that the alternative splicing of gene products is a by-product of an alternative way of regulation of LH receptor gene expression (21, 22) . Fetal testicular LH receptor mRNA expression has not been documented in humans. However, binding of hCG to fetal testicular tissue and the correlated hCG and testosterone levels during fetal life suggest that functional LH receptors are expressed in Leydig cells at an early fetal age of 9 weeks (1 1 ,2 3 , 24). steroidogenesis in other organs such as the adrenal gland, in both syndromes, LH receptor function has been shown to be modified, in Ihe following sec!ions, mutational changes in the LI I receptor in these two syndromes and their consequnces for Leydig cell function will be dicussed.
Disorders of sex differentiation
Many disorders of male sex differentiation have been described, all of which are due to either insuflicient availability of testosterone (androgens) or the lack of response of the target tissues to this hormone. Muta tions in the androgen receptor gene lead to androgen insensitivity of target tissues, which causes partial or complete male pseudohermaphroditism (25) . Before puberty a similar external phenotype is initially found in cases with dclicieney of the enzyme 5n-reduciase type 2 that converts testosterone to the more active metabolite dihydrotestosterone (f>), although at puberty the testes start to secrete high amounts of testosterone, which sometimes results in extensive virilization. Also, changes in the activity of steroidogenic enzymes in the testosterone synthesis pathway, such as Cl 7-204yase/ 17a~hydroxylase or 3/^-hydroxysteroid dehydrogenase, affect male sex differentiation. Because these enzvme dysfunctions also manifest themselves in the adrenal gland, they also cause adrenal hyperplasia (26) .
In two familial disorders-familial male-limited precocious puberty and Leydig cell hypoplasia-Leydig cell function is altered without changes in Familial m ale-lim ited precocious puberty Familial male-limited precocious puberty (I'MPP), also named lestotoxicosis, has been described initially in 1981 (27), This familial form of precocious puberty is characterized by an excessive secretion of testosterone by Leydig cells in the absence of elevated levels of pituitary gonadotrophins (28, 29). ll is different from true (central) precocious puberty, which involves premature activation of the hypothalamic GnRH pulse generator ( SO). In FMPP. excessive androgen produc tion occurs probably also in the lelus. because enlarge ment of the external genitalia has been noted at birth in some cases (SI). A circulating testis-stimulating factor that activates only human. Leydig cells, but not rodent Leydig cells, has been suggested to be the cause of FMPP ( 12) , but this report was not confirmed. The increased testosterone production might also be the result of an inherent change in the Leydig cells themselves, and therefore the LH receptor gene of these patients was investigated, Mutations in the LH receptor could change the behaviour of ihe receptor in such a manner that it would signal continuously through G., to the adenylyl cyclase system, activating the Leydig cells without the ligand being present. In their investigations of the o r adrenergic receptor, Lelkowitz and co-workers ( i i) had shown that changing an alanine residue in the third intracellular loop of this receptor to any other amino acid residue resulted in different levels of constitutive activation of the phosphatidylinositide pathway with out ligand being present. Furthermore in mice that dominantly express a coat-colour trait, an MSI I receptor gene that consititulively activates adenvlvl cvelase was V * f'1 4 I* described ( J4). Familial diseases as a result of such conslitutivclv activated G protein'-coupled receptors had not been described at that time, but on the basis of these reports, DNA analysis of the LH receptor gene was undertaken with emphasis on the third intracellular loop and the sixth transmembrane segment. Two mutations were reported, methionine at position 571 to isoleucine ( Jr) and aspartate at position 578 to glycine t JS. Sb). When transfected into COS or HKK29 5 cell lines, the cells that expressed the mutant receptor species indeed showed an increased basal cAMP level when compared to cells expressing the wild-tvpe receptor (Fig. I ) .
When hCG was added to the transfected cells, a doseresponse relationship was found with an KDsn which is very similar to the KDSU of the wild-type receptor. To HUH | l;N U K 'KINOI. l 'Nh, 1 W
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Fía. I. Mutation in patients wllh familial male-limited precocious puberty causes t'<iriNíítutivc UJ receptor activity. Hitman chorionic gonadotrophin thlV» I dependent eAMF production in cells expressing lilt* wild-type or mutant lmethionines' 1 to Isoleudne or aspartate*' sto glycine) LH receptor. Mutant receptors show an Increased basal cAMl* production bul a decreased maximal response to h t\l. (Figure taken from Ret'. 54.) date, eleven dillerenl LH receptor mutations in FMPP have been described (Fig. 2) , Most imitations are found in the sixth transmembrane segment and Hanking third intracellular loop. However, two mutations (methionine to threonine and isoleueine s-t to leucine) were found in other transmembrane segments, the second and fifth, respectively* These findings indicate that the sixth transmembrane segment and the third intracellular loop are major determinants of (3 protein coupling in the LH receptor, but that the second and fifth transmembrane segments are also involved, Data obtained with other G protein-coupled receptors implicate similar receptor regions in G protein coupling (see Refs, 37 and 38). Careful examination of the amino acid changes found in FMPP patients reveals that although some alterations involve a major change of amino acid type, such as aspartate578 to glycine or tyrosine, or cysteine581 to arginine, other amino acid changes such as alanine568 to valine or isoleucine 5/5 to leucine, do not. it seems that any change of several amino acid residues may result in a constitutively active receptor. The receptor molecule appears to be finely tuned, and can be thought to be activated similar to a spring or mouse-trap when either the hormone binds or an amino acid is changed. The amino acid residues that are changed in FMPP patients are obvious candidates in future investigations of the structure-function relationship of the LH receptor during activation by LH or hCG.
it would appear that the LH receptor mutations found in FMPP patients are indeed the cause of their precocious puberty, but it is difficult to obtain formal proof. One of the experiments that could provide such proof would be a transgenic mouse with a targeted activating LH receptor gene mutation. In another approach, we have chosen to use a mouse Leydig cell line, MA-10 cells (39), to test the mutations that were found in FMPP patients. The MA-10 cells were transfected with wild-type and mutated LH receptor eDNA constructs, and basal and maximally hCGstimulated pregnenolone production was determined. Because MA-10 cells carry the mouse wild-type LH receptor, the transfectcd cells partially mimic the situation in Leydig cells of an PMPP patient, where also both wild-type and mutated alleles are expressed. Vi(j. 1. FJTecL of mutant familial male-limited precocious puberty LU receptor expression on basal cAMP and pregnenolone production by mouse tumour Leydig ceils (MA 10 ), Cells transfected with tvild-type and mutant LH receptors were incubated in the absence or presence oi a maximally stimulating dose of hCCï, Basal cAMP or pregnenolone production is expressed as a percentage of the maximal response to hCCi, Both cAMP and pregnenolone productions are increased in cells transfected with mutant receptor, in ihe absence o fh l'il nr LII. dominant phenotype; cells transfected with a constitulively active LH receptor show a higher cAMP level and, more importantly tor ihe FMPP phenotype, also a higher steroid production. These results demonstrate that in Leydig cells of FMPP patients the increased basal cAMP level in the absence of hormone will indeed result in increased testosterone production, and subsequently in precocious puberty. patients was investigated (4N. 49) . In contrast with the LH receptor gene in FMPP patients, it can be expected that DNA changes (he result in a loss of function of the LH receptor gene will be found anywhere in the gene and may range from amino acid changes, to shifted reading frames or deletions of part of the gene. Two groups have reported on LH receptor gene mutations in LCH patients. In one of these papers, two 4b,XY sisters born from consanguineous parents were found to be homozygous for a missense mutation that resulted in the change of alanine at position 59 5, located just outside the sixth transmembrane segment, into a proline residue (Figure 4)(48) . When expressed in transfected cells, this mutated LH receptor was found to bind hCG with a normal Kj. although the receptor was expressed at a much lower level than the wild-type receptor. However, the proline residue changed (he LII receptor in such a way that, in spite id* the higlwiffmity hCCi binding, no eouping to adenylyl cyclase could be demonstrated in the absence or presence of hCG (Fig. 4) . In another patient the situation was more complex (49). One allele of the LH receptor gene was found to contain a nonsense mutation resulting in the introduction of a stop codon at position 545 in the lifth transmembrane segment of the transmembrane domain. Similar to the w | I I alanine'* to proline mutation, in vitro expression of this truncated receptor showed diminished binding with the same affinity compared to the wild-type Li { receptor, and no coupling to adenylyl cyclase. The other LH receptor allele did not show the same mutation, suggesting that the patients were compound hetero zygotes. The identity of the mutation in this LI! receptor allele has not been established yet 149), Two additional mutations (asparagine'**11 to serine and serine Mi> to tyrosine) have been published recently in an abstract (50). The mutation at position 291 lies in the extracellular domain, and this receptor molecule may be expected to have lost ligand binding. 'This mutation has not been tested in vitro, however. The seriuehlh to tyrosine mutation showed similar behaviour in vitro to the LH receptors carrying an alanine^ to proline mutation or a stop codon at position 545.
Leydig cell hypoplasia

The clinical mirror-hnage of FMPP is ihe Leydig cell hypoplasia syndrome (LCH). Patients can present with a external genita lia, or with a more severe form with complete male pseudohermaphroditism (40-47). The testes of the patients show low numbers of Leydig cells in the mildly affected patients, to a complete absence of adult Leydig cells in the pseudo-hermaphrodites. The syn drome of Leydig cell hypoplasia is an autosomal recessive condition. In some studies testicular LH binding was absent, which could either be the cause or the consequence of the absence of Leydig cells (47). In analogy with the studies on FMPP. the LII receptor gene in LCH
The mutations described above were found in severe cases of LCH. In patients that are affected more mildly, amino acid changes may be found that do not abolish receptor function completely, but rather may result in decreased activity such as diminished LH binding affinity or less-efficient t! protein coupling. Milder mutations may allow correlations beiween the proper ties of the amino acid residues that have changed and the severity of the LCH syndrome, and hopefully will f 4
give directions toward the further functional character ization of the receptor subdomains, such as the domains involved in the regulation of receptor transport from ihe endoplasmic reticulum to the plasma membrane or glycosylation of the extracellular ligand binding domain.
Concluding remarks
Although identification of LH receptor gene mutations has just started, a distinct pattern of mutations appears to evolve. Fourteen mutations that have been published are located in the transmembrane domain of the LH receptor; only one mutation (asparagine*111 to serine) changes the extracellular LH binding domain, although the effect of this mutation on LH receptor function was not tested in vitro. However. this overrepresentation of (lit* transmembrane domain should not in* emphasized loo much because this region was tlu* domain that was lirsl subjected to UN A analysis, Rm*ntly, the intronexon structure of tin* oilier exons of the large human hi I reeeplor gent* has been determined, allowing the study of the other exons of the LI 1 receptor gene (SI). Most LI 1 receptor mutations found in FMPP patients are located in the third intracellular loop or in the sixth transmembrane segment i!;ig> 2). This linding underscores the Importance of this receptor region in Cl protein coupling, as was already suggested from studies using sitedirected mutagenesis (see Kef. 52), However, it is of interest that the two imitations that were identified in the l.CTl patients both lie in the last exon that encodes the transmemhrane domain. It remains to be estab lished by the identification of other Lt'H LI I receptor gene mutations whether a selective pressure exists against mutations in the other exons that encode the extracellular Llf/ht'C* binding domain. Now that the molecular basis of the syndromes of FMPP and Lt'H has been established, conclusions can be drawn about the relative importance of LH/ht'C! during sexual differentiation of the male and the role of androgens in spermatogenesis, In the LOT patients with the alanine^* lo proline mutation the absence of LH/hCti stimulation of Leydig cells did not lead to a complete absence of androgens. The presence of the androgen-dependent epididymides and vasa deferentia assocn that there is autonomous (LH/hC(l-independent) andro gen production by Leydig cells during fetal male sex differentiation. Probably this autonomous androgen production is relatively low, and only effective at a small distance from the developing testis, as indicated by the absence of oilier androgen-dependent organs such as the prostate or seminal vesicles. Epididymides and vasa deferentia are not found in patients that suffer from complete androgen insensitivity and do not have a functional androgen receptor gene (25) have I ho short stature associated with precocious puberty but abnormalities such as Leydig cell neoplasia or infertility have not been reported, with the exception of one individual in a large pedigree who was reported to be infertile (28). Postpubertal LH-stinuilated andro gen levels are much higher than the androgen productions in the FMPP boys, and may explain the absence of effects of the activating L11 receptor mutations in adult life, The female carriers of an FMPP LI I receptor gene mutation, which in men leads to precocious puberty, seem to be without symptoms. In the light of the precise regulation of the menstrual cycle in women, this seems puzzling. Although no studies of female carriers of FMMP I i i receptor mutations have been reported, expression of constitutively active LM receptors in preovulatory follicles might lead to premature ovula tions. However, there is no indication of impaired fertility in the female carriers. Possibly, at the time of ovulation the follicular LI1 receptors have to be stimulated to a high degree to induce ovulation. As can be seen readily from the hC(5 dose-response curves depicted in Fig. I , the basal cAMP level is increased in cells expressing a constitutively active receptor, but an paper are parlially supported by The Netherlands Organization fur Scientific Research through NWO-MW, y i * increase enhancement of cAMP production, thus allowing granulosa cells of female FMPP carriers to respond normally to the ovulatory LH peak. > 1.1 T roronlnr muhilinns has UO effect 00 • is not expressed in ovaries before birth (2 1 ). However, a 4b, XX sister in the family described by Kremer el al. (48} was found to be homozygous for the same inactivating LH receptor gene mutation, and presents with primary amenorrhoea, but has normally developed sex char acteristics (Dr S Toledo, pers. comm.) (48), This is consistent with the requirement for an active LH signal transduction system for ovulation to occur, In this respect it is of interest to note that recently an inactivating mutation in the FSII receptor gene has been found in women with ovarian dysgenesis. In these women, the inability of the ovaries to respond to FKH results in the absence of follicle growth, low gonadal hormone production and variably developed secondary sex characteristics in the presence of high levels of FSH and LIL It is tempting to speculate that other patients with female infertility may also be carriers of more or less severe LH or FSH receptor gene mutations, A combination of two mutations with a mild phenotype (two alleles) or of one mutation with a severe phenotype (one allele) could lead to a decreased LH or FSH receptor response and disturbance of the precise timing that is necessary for ovulation of the preovulatory follicle.
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